Top 100 Contractors in NAICS 325414: Biological Product (except Diagnostic) Manufacturing, FY2024

Parent companies by net contract obligations Oct 1, 2023 – Sep 30, 2024 Code page on GovTribe

The top 10 won 95% of FY2024 NAICS 325414 contract dollars

Ranking facts

Contract obligations
$1,045,197,656 Net of deobligations, by contracts coded NAICS 325414
Contractors
178 Parent companies with an obligation
Largest contractor
Advanced Technology International $501 million, 46.3% of obligations
Data as of

Contract actions from FPDS (SAM.gov). How the rankings work · Download all 100 rows as CSV

Full ranking

Rank Contractor Net obligations Share Trend
1 $501,155,622
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
2 $270,999,520
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
3 $99,957,720
Rank history: not on the FY2021–FY2023 lists and #1 in FY2025; new.
4 $56,773,945
Rank history: #21 in FY2021, #79 in FY2022, #13 in FY2023 and #3 in FY2025; up 9 since FY2023.
5 $25,692,481
Rank history: #7 in FY2021, not on the FY2022–FY2023 lists and #5 in FY2025; returned.
6 $25,079,930
Rank history: #26 in FY2021, #3 in FY2022, #3 in FY2023 and #10 in FY2025; down 3 since FY2023.
7
VALNEVA Through Valneva Usa, Inc.
$22,400,000
Rank history: #6 in FY2021, #5 in FY2022, #5 in FY2023 and not on the FY2025 list; down 2 since FY2023.
8
Valneva USA Inc.
$16,016,000
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
9 $8,375,000
Rank history: not on the FY2021–FY2023 lists and #9 in FY2025; new.
10
Boehringer Ingelheim Animal Health USA Inc
$7,683,804
Rank history: #28 in FY2021, #23 in FY2022, #7 in FY2023 and #6 in FY2025; down 3 since FY2023.
11 $5,335,318
Rank history: not on the FY2021–FY2023 lists and #4 in FY2025; new.
12 $2,657,356
Rank history: #13 in FY2021, #8 in FY2022, #8 in FY2023 and #7 in FY2025; down 4 since FY2023.
13 $2,647,181
Rank history: #18 in FY2021, #10 in FY2022, #11 in FY2023 and #12 in FY2025; down 2 since FY2023.
14
Sanofi Pasteur Inc. 2 awardees, including Sanofi Vaccines US Inc.
$2,018,558
Rank history: not on the FY2021–FY2023 lists and #2 in FY2025; new.
15 $1,528,029
Rank history: not on the FY2021–FY2023 lists and #23 in FY2025; new.
16 $1,390,759
Rank history: #54 in FY2021, not on the FY2022–FY2023 lists and #15 in FY2025; returned.
17 $1,048,799
Rank history: #19 in FY2021, #13 in FY2022, #10 in FY2023 and #17 in FY2025; down 7 since FY2023.
18 $803,636
Rank history: #24 in FY2021, #16 in FY2022, #14 in FY2023 and #45 in FY2025; down 4 since FY2023.
19 $800,450
Rank history: #30 in FY2021, #94 in FY2022, #21 in FY2023 and #13 in FY2025; up 2 since FY2023.
20 $743,203
Rank history: #34 in FY2021, #34 in FY2022, #28 in FY2023 and not on the FY2025 list; up 8 since FY2023.
21 $648,968
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
22 $641,835
Rank history: not on the FY2021 list, #31 in FY2022, #31 in FY2023 and #50 in FY2025; up 9 since FY2023.
23 $630,605
Rank history: #88 in FY2021, #32 in FY2022, #48 in FY2023 and #30 in FY2025; up 25 since FY2023.
24 $611,781
Rank history: #17 in FY2021, #9 in FY2022, #6 in FY2023 and not on the FY2025 list; down 18 since FY2023.
25 $611,500
Rank history: not on the FY2021–FY2023 lists and #16 in FY2025; new.
26 $530,862
Rank history: not on the FY2021–FY2023 lists and #20 in FY2025; new.
27 $377,572
Rank history: #25 in FY2021, #19 in FY2022, not on the FY2023 list and #19 in FY2025; returned.
28 $360,916
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
29
Cerilliant Corporation 2 awardees, including Sigma-Aldrich, Inc. and EMD Millipore Corp
$337,655
Rank history: not on the FY2021–FY2023 lists and #77 in FY2025; new.
30 $308,827
Rank history: not on the FY2021–FY2023 lists and #46 in FY2025; new.
31 $290,347
Rank history: #68 in FY2021, #53 in FY2022, #72 in FY2023 and #49 in FY2025; up 41 since FY2023.
32 $287,037
Rank history: #57 in FY2021, #35 in FY2022, #25 in FY2023 and not on the FY2025 list; down 7 since FY2023.
33 $273,260
Rank history: #44 in FY2021, #36 in FY2022, #36 in FY2023 and not on the FY2025 list; up 3 since FY2023.
34 $272,615
Rank history: not on the FY2021 list, #37 in FY2022, #38 in FY2023 and #38 in FY2025; up 4 since FY2023.
35 $260,989
Rank history: #56 in FY2021, #42 in FY2022, #34 in FY2023 and #34 in FY2025; down 1 since FY2023.
36 $253,856
Rank history: #16 in FY2021, #12 in FY2022, #46 in FY2023 and #75 in FY2025; up 10 since FY2023.
37 $250,001
Rank history: not on the FY2021–FY2023 lists and #40 in FY2025; new.
38 $245,590
Rank history: #52 in FY2021, #38 in FY2022, #65 in FY2023 and #53 in FY2025; up 27 since FY2023.
39 $228,679
Rank history: not on the FY2021–FY2023 lists and #33 in FY2025; new.
40 $226,733
Rank history: #47 in FY2021, #21 in FY2022, #17 in FY2023 and not on the FY2025 list; down 23 since FY2023.
41 $216,198
Rank history: not on the FY2021–FY2022 lists, #16 in FY2023 and #36 in FY2025; down 25 since FY2023.
42 $196,531
Rank history: #27 in FY2021, #25 in FY2022, #35 in FY2023 and not on the FY2025 list; down 7 since FY2023.
43 $196,252
Rank history: #61 in FY2021, #49 in FY2022, #30 in FY2023 and not on the FY2025 list; down 13 since FY2023.
44 $189,511
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
45 $186,611
Rank history: #35 in FY2021, #22 in FY2022, #24 in FY2023 and #48 in FY2025; down 21 since FY2023.
46 $186,344
Rank history: #15 in FY2021, #30 in FY2022, #27 in FY2023 and #39 in FY2025; down 19 since FY2023.
47 $172,084
Rank history: #75 in FY2021, #66 in FY2022, #45 in FY2023 and #44 in FY2025; down 2 since FY2023.
48 $171,193
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
49 $165,251
Rank history: #53 in FY2021, not on the FY2022 list, #23 in FY2023 and #22 in FY2025; down 26 since FY2023.
50 $155,655
Rank history: #50 in FY2021, #67 in FY2022, #53 in FY2023 and #56 in FY2025; up 3 since FY2023.
51 $152,756
Rank history: #72 in FY2021, #15 in FY2022, #37 in FY2023 and #99 in FY2025; down 14 since FY2023.
52 $152,203
Rank history: #12 in FY2021, #7 in FY2022, #12 in FY2023 and not on the FY2025 list; down 40 since FY2023.
53 $145,144
Rank history: #62 in FY2021, #46 in FY2022, #55 in FY2023 and #51 in FY2025; up 2 since FY2023.
54 $143,624
Rank history: #41 in FY2021, #39 in FY2022, #42 in FY2023 and #79 in FY2025; down 12 since FY2023.
55 $142,622
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
56
Gemini Bioproducts LLC
$141,603
Rank history: not on the FY2021–FY2023 lists and #66 in FY2025; new.
57 $132,000
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
58 $127,276
Rank history: not on the FY2021–FY2023 lists and #52 in FY2025; new.
59 $121,476
Rank history: #69 in FY2021, #56 in FY2022, #81 in FY2023 and not on the FY2025 list; up 22 since FY2023.
60 $121,295
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
61 $109,950
Rank history: not on the FY2021–FY2022 lists, #82 in FY2023 and not on the FY2025 list; up 21 since FY2023.
62 $104,550
Rank history: not on the FY2021 list, #85 in FY2022, #71 in FY2023 and not on the FY2025 list; up 9 since FY2023.
63 $100,000
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
64
Takara Holdings Inc. Through Takara Bio Usa, Inc.
$94,811
Rank history: #79 in FY2021, #80 in FY2022, not on the FY2023 list and not on the FY2025 list; returned.
65 $90,000
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
66 $87,600
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
67 $87,535
Rank history: not on the FY2021 list, #95 in FY2022, #56 in FY2023 and #62 in FY2025; down 11 since FY2023.
68 $84,655
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
69 $82,468
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
70 $81,199
Rank history: not on the FY2021–FY2023 lists and #41 in FY2025; new.
71 $80,300
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
72 $79,275
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
73 $75,200
Rank history: not on the FY2021–FY2023 lists and #25 in FY2025; new.
74
DNA Twopointo Inc.
$75,000
Rank history: not on the FY2021–FY2022 lists, #75 in FY2023 and #64 in FY2025; up 1 since FY2023.
75
VWR International LLC
$73,588
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
76
Takara BIO USA Inc.
$72,088
Rank history: not on the FY2021–FY2023 lists and #93 in FY2025; new.
77
Fluent Biosciences Inc
$70,279
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
78 $68,700
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
79 $67,500
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
80 $65,991
Rank history: not on the FY2021–FY2022 lists, #57 in FY2023 and #60 in FY2025; down 23 since FY2023.
81 $64,270
Rank history: #81 in FY2021, not on the FY2022–FY2023 lists and not on the FY2025 list; up 25 since FY2023.
82 $60,415
Rank history: #23 in FY2021, #40 in FY2022, not on the FY2023 list and not on the FY2025 list; returned.
83 $59,328
Rank history: not on the FY2021 list, #70 in FY2022, #96 in FY2023 and #54 in FY2025; up 13 since FY2023.
84 $56,297
Rank history: #45 in FY2021, not on the FY2022–FY2023 lists and #43 in FY2025; returned.
85 $55,316
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
86
Sartorius Corporation
$55,084
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
87 $54,903
Rank history: not on the FY2021–FY2023 lists and #61 in FY2025; new.
88 $53,964
Rank history: not on the FY2021–FY2023 lists and #87 in FY2025; new.
89 $48,742
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
90 $46,251
Rank history: not on the FY2021 list, #76 in FY2022, not on the FY2023 list and not on the FY2025 list; returned.
91 $43,674
Rank history: not on the FY2021–FY2023 lists and #86 in FY2025; new.
92 $42,948
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
93
Biofire Defense LLC
$40,632
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
94 $37,000
Rank history: #98 in FY2021, not on the FY2022–FY2023 lists and not on the FY2025 list; returned.
95 $36,050
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
96
PIE Scientific LLC
$35,696
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
97 $34,832
Rank history: not on the FY2021 list, #99 in FY2022, not on the FY2023 list and not on the FY2025 list; up 31 since FY2023.
98 $31,264
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
99 $31,206
Rank history: not on the FY2021–FY2023 lists and not on the FY2025 list; new.
100 $29,400
Rank history: #99 in FY2021, #78 in FY2022, #85 in FY2023 and not on the FY2025 list; down 15 since FY2023.
Show 75 more

100 of 178 contractors listed here. See the rest on GovTribe.

How this ranking works

  • Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
  • Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $1.08 billion obligated before deobligations, so they never pass 100%.
  • Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
  • Fiscal year 2024 ran Oct 1, 2023 – Sep 30, 2024. The Department of Defense reports its contract actions to FPDS about 90 days late, so a fiscal year is ranked once they're in, in February, and the list doesn't change after.
  • Rank changes compare with FY2023. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
  • Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list. The step from FY2023 takes the color of the rank change beside it.
  • Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.

Quick answers

Who were the top 10 NAICS 325414 contractors in FY2024?

1. Advanced Technology International ($501M), 2. Analytic Services Inc. ($271M), 3. Emergent Biosolutions Inc. ($100M), 4. Glaxosmithkline LLC ($56.8M), 5. Seqirus Inc. ($25.7M), 6. Seqirus USA Inc. ($25.1M), 7. VALNEVA ($22.4M), 8. Valneva USA Inc. ($16M), 9. Boehringer Ingelheim Animal Health France ($8.38M), 10. Boehringer Ingelheim Animal Health USA Inc ($7.68M).

On GovTribe

Research every contractor on this list

  • Every contract, task order and IDV they hold
  • Their subsidiaries, teammates and competitors
  • Open opportunities they're positioned for
  • Alerts when they win new work